DK325487D0 - Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling - Google Patents

Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling

Info

Publication number
DK325487D0
DK325487D0 DK325487A DK325487A DK325487D0 DK 325487 D0 DK325487 D0 DK 325487D0 DK 325487 A DK325487 A DK 325487A DK 325487 A DK325487 A DK 325487A DK 325487 D0 DK325487 D0 DK 325487D0
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical compositions
parenteral application
parenteral
application
Prior art date
Application number
DK325487A
Other languages
English (en)
Other versions
DK325487A (da
Inventor
Leo Geller
Peter Glanzmann
Martin Kueenzi
Kurt Weiss
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK325487D0 publication Critical patent/DK325487D0/da
Publication of DK325487A publication Critical patent/DK325487A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK325487A 1986-06-26 1987-06-25 Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling DK325487A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH258386 1986-06-26

Publications (2)

Publication Number Publication Date
DK325487D0 true DK325487D0 (da) 1987-06-25
DK325487A DK325487A (da) 1987-12-27

Family

ID=4237056

Family Applications (1)

Application Number Title Priority Date Filing Date
DK325487A DK325487A (da) 1986-06-26 1987-06-25 Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling

Country Status (6)

Country Link
EP (1) EP0252004A1 (da)
JP (1) JPS638339A (da)
KR (1) KR890000096A (da)
AU (1) AU7468887A (da)
DK (1) DK325487A (da)
PT (1) PT85155A (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6447435A (en) * 1987-08-18 1989-02-21 Oriental Yeast Co Ltd Dispersant for biologically active peptide
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
CA2007901A1 (en) * 1989-01-27 1990-07-27 Hiroshi Matsuda Urokinase precursor-lipid composite
NZ232865A (en) * 1989-03-21 1992-07-28 Hoffmann La Roche A mixed-micelle solution comprising a micelle former and an immunomodulator
JPH02292226A (ja) * 1989-05-08 1990-12-03 Shigemi Fujisaki 障害された神経細胞賦活予防治療剤
DE3938030A1 (de) * 1989-11-13 1991-05-16 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
DE19522693A1 (de) * 1995-06-22 1997-01-02 Dianorm G Maierhofer Gmbh Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
US6344576B1 (en) 1997-08-18 2002-02-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Phospholipid-analogous compounds
WO2008040799A2 (en) * 2006-10-06 2008-04-10 Boehringer Ingelheim International Gmbh Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release
RU2618402C1 (ru) * 2015-11-23 2017-05-03 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ прогнозирования развития тромботических осложнений после панкреатодуоденальной резекции при раке головки поджелудочной железы
CN112074274B (zh) * 2018-03-19 2024-03-26 艾匹赛特制药公司 用于治疗因缺钙引起的病状的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US158707A (en) * 1875-01-12 Improvement in spring-seat supports
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
US4649155A (en) * 1983-07-22 1987-03-10 Hoffmann-La Roche Inc. Injectable solutions
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method

Also Published As

Publication number Publication date
EP0252004A1 (de) 1988-01-07
JPS638339A (ja) 1988-01-14
PT85155A (en) 1987-07-01
AU7468887A (en) 1988-01-07
KR890000096A (ko) 1989-03-11
DK325487A (da) 1987-12-27

Similar Documents

Publication Publication Date Title
DK154085A (da) N-aryl-n-(4-piperidinyl)-amider samt farmaceutiske praeparater deraf
DK25992A (da) Quinolinderivater, deres fremstilling samt farmaeutisk praeparat indeholdende saadanne derivater
DK52388D0 (da) Polyaminderivater samt fremgangsmaader til deres fremstilling
DK454188A (da) 2-oxo-1-sulfonylaminocarbonyl-azetidiner samt fremgangsmaade til deres fremstilling
DK184087D0 (da) Farmaceutiske praeparater med forbedret biotilgaengelighed
DK413987D0 (da) Farmaceutiske praeparater
DK670587D0 (da) Fremgangsmaade til screening af stabiliseringsmidler til rta- og rta-immunkonjugatpraeparater samt stabile farmaceutiske sammensaetninger omfattende rta-immunkonjugater
DK325487D0 (da) Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling
DK403287A (da) 1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling
DK539087D0 (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK652787D0 (da) Farmaceutiske praeparater
MX172943B (es) Formulacion farmaceutica
DK447887A (da) Frysetoerrede farmaceutiske praeparater
DK540887A (da) Iminooxazolidiner, fremgangsmaade til deres fremstilling samt anvendelse deraf
IT1216814B (it) Composizioni farmaceutiche
DK380787D0 (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DK574087D0 (da) Anti-hypertensivt praeparat
DK428287A (da) Nasalt farmaceutisk praeparat
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater
DK63089A (da) 1-aminomethyl-3-(2,4-diflour-3-chlorphenyl)-4-cyanopyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse
BR1100961A (pt) Composto e composição farmacêutica
LV5728B4 (lv) Farmaceitiskas kompozicijas
LV5734B4 (lv) Farmaceitiskas kompozicijas
SE8602975D0 (sv) Farmaceutisk beredning